Hypoxia is a feature of most solid tumours and predicts for poor prognosis. In radiobiological hypoxia (<0.1% O2) cells become up to three times more resistant to radiation. The biological response to radiobiological hypoxia is one of few physiologically relevant stresses that activates both the unfolded protein and DNA damage responses (UPR and DDR). Links between these pathways have been identified in studies carried out in normoxia. Based in part on these previous studies and recent work from our laboratory, we hypothesised that the biological response to hypoxia likely includes overlap between the DDR and UPR. While inhibition of the DDR is a recognised strategy for improving radiation response, the possibility of achieving this through...
Purpose: Tumor hypoxia is unequivocally linked to poor radiotherapy outcome. This study aimed to ide...
BACKGROUND AND PURPOSE: Tumour hypoxia contributes to failure of cancer treatment through its abilit...
YesTumour hypoxia is associated with poor patient prognosis and therapy resistance. A unique transcr...
Acute and chronic hypoxia exists within the microenvironment of solid tumours and drives therapy res...
The hypoxic tumour is a chaotic landscape of struggle and adaption. Against the adversity of oxygen ...
BACKGROUND: Low oxygen (O(2)) availability, a condition called hypoxia, has different and profound c...
Background and purpose: Hypoxia is a common feature of the microenvironment of solid tumors which ha...
Cancers are often riddled with areas of low oxygen concentration (i.e. hypoxic regions) and these ar...
Hypoxia has been linked with increased resistance to treatment in various solid tumors, including he...
Low oxygenation, or hypoxia, is prevalent in human solid tumours and is a known contributor to thera...
Exposure to hypoxia-induced replication arrest initiates a DNA damage response that includes both AT...
Contains fulltext : 87690.pdf (publisher's version ) (Open Access)Tumor hypoxia is...
Mesenchymal stromal cells (MSCs) are radioresistant bone marrow progenitors that support hematopoies...
During severe hypoxia (<0.01% oxygen) the protein folding machinery becomes dysfunctional, resulting...
Hypoxia has been linked with increased resistance to treatment in various solid tumors, including he...
Purpose: Tumor hypoxia is unequivocally linked to poor radiotherapy outcome. This study aimed to ide...
BACKGROUND AND PURPOSE: Tumour hypoxia contributes to failure of cancer treatment through its abilit...
YesTumour hypoxia is associated with poor patient prognosis and therapy resistance. A unique transcr...
Acute and chronic hypoxia exists within the microenvironment of solid tumours and drives therapy res...
The hypoxic tumour is a chaotic landscape of struggle and adaption. Against the adversity of oxygen ...
BACKGROUND: Low oxygen (O(2)) availability, a condition called hypoxia, has different and profound c...
Background and purpose: Hypoxia is a common feature of the microenvironment of solid tumors which ha...
Cancers are often riddled with areas of low oxygen concentration (i.e. hypoxic regions) and these ar...
Hypoxia has been linked with increased resistance to treatment in various solid tumors, including he...
Low oxygenation, or hypoxia, is prevalent in human solid tumours and is a known contributor to thera...
Exposure to hypoxia-induced replication arrest initiates a DNA damage response that includes both AT...
Contains fulltext : 87690.pdf (publisher's version ) (Open Access)Tumor hypoxia is...
Mesenchymal stromal cells (MSCs) are radioresistant bone marrow progenitors that support hematopoies...
During severe hypoxia (<0.01% oxygen) the protein folding machinery becomes dysfunctional, resulting...
Hypoxia has been linked with increased resistance to treatment in various solid tumors, including he...
Purpose: Tumor hypoxia is unequivocally linked to poor radiotherapy outcome. This study aimed to ide...
BACKGROUND AND PURPOSE: Tumour hypoxia contributes to failure of cancer treatment through its abilit...
YesTumour hypoxia is associated with poor patient prognosis and therapy resistance. A unique transcr...